1354 / 1481
Reduces recurrence
10 year gain 1.3% (N-) and 10.6% (N+)
Reduces breast cancer mortality
20 year gain 2.2% (N-) and 8.1%
(N+)
ONE BREAST CANCER DEATH IS
AVOIDED FOR EVERY FOUR LOCAL
RECURRENCES AVOIDED
The Lancet 2014 , Volume 383 , Issue 9935 , 2127 - 2135
Post-mastectomy
: Meta-análisis EBCTG
(Node (-): 700 pts); Node (+): 3131 pts)
WHY DO WE USE ADJUVANT RT IN
BREAST CANCER PATIENTS? (ii)